✦ LIBER ✦

Pharmacokinetics, safety, and efficacy of DPP-4 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes mellitus and renal or hepatic impairment. A systematic review of the literature

✍ Scribed by Giorda, Carlo B.; Nada, Elisa; Tartaglino, Barbara

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Erratum to: Pharmacokinetics, safety, an

✍ Giorda, Carlo B.; Nada, Elisa; Tartaglino, Barbara 📂 Article 📅 2014 🏛 Springer 🌐 English ⚖ 154 KB

Specific actions of GLP-1 receptor agoni

✍ Stéphane Dalle; Rémy Burcelin; Pierre Gourdy 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 699 KB

Safety, tolerability, pharmacokinetics a

✍ Seino, Yutaka; Nakajima, Hiromu; Miyahara, Hajime; Kurita, Takashi; Bush, Mark A 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 230 KB

The safety of dipeptidyl peptidase-4 (DP

✍ Kawalec, Paweł ;Mikrut, Alicja ;Łopuch, Sylwia 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 867 KB

Long-term treatment with the dipeptidyl

✍ M. Nowicki; I. Rychlik; H. Haller; M. Warren; L. Suchower; I. Gause-Nilsson; K-M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB

Efficacy and Safety of Long-Acting Gluca

✍ Pinelli, N. R.; Hurren, K. M. 📂 Article 📅 2011 🏛 Harvey Whitney Books Company 🌐 English ⚖ 278 KB